Researcher.Life Logo

Postepy Dermatologii I Alergologii : Impact Factor & More

eISSN: 2299-0046pISSN: 1642-395X
JournalOpen Access

Key Metrics

CiteScore
2.1
Impact Factor
< 5
SJR
Q3Dermatology
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Postepy Dermatologii I Alergologii

Postepy Dermatologii I Alergologii Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TERMEDIA PUBLISHING HOUSE LTD
Language English
Frequency Bi-monthly
Article Processing ChargesEUR 450 | PLN 2050
Publication Time13
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorPolish Society of Allergology
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
Publication Time 13
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Postepy Dermatologii I Alergologii ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Postepy Dermatologii I Alergologii

Stress: an important cofactor in patients with lichen planopilaris and frontal fibrosing alopecia
  • 22 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Papulonodular mucinosis with or without systemic lupus erythematosus: a retrospective study
  • 20 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Papular sarcoidosis arising in a patient within the background of macular amyloidosis: a rare confluence
  • 17 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis
  • 17 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Psychological distress statistically mediates the association between vitiligo severity and health-related quality of life: a cross-sectional study from Kandahar, Afghanistan
  • 16 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Immunological and molecular biomarkers in skin allergy therapy: monitoring inflammation, barrier function, and treatment response
  • 15 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Stress: an important cofactor in patients with lichen planopilaris and frontal fibrosing alopecia
  • 22 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Papulonodular mucinosis with or without systemic lupus erythematosus: a retrospective study
  • 20 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Papular sarcoidosis arising in a patient within the background of macular amyloidosis: a rare confluence
  • 17 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Assessment of adalimumab used in a patient with hemorrhagic rheumatoid neutrophilic dermatosis
  • 17 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Psychological distress statistically mediates the association between vitiligo severity and health-related quality of life: a cross-sectional study from Kandahar, Afghanistan
  • 16 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii
Immunological and molecular biomarkers in skin allergy therapy: monitoring inflammation, barrier function, and treatment response
  • 15 Apr 2026
  • Advances in Dermatology and Allergology/Post\u0229py Dermatologii i Alergologii

FAQs on Postepy Dermatologii I Alergologii